fluoro prostaglandinas utilizadas como hipotensores oculares. . Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma. Generate link with comments. Analogos de tetrahidrofurano sustituido de prostaglandinas como hipotensores oculares. Abstract. translated from. Classifications. En los casos más leves, es muy probable que la enfermedad se mantenga bajo control con la utilización de colirios hipotensores oculares. Estos colirios se han .

Author: Faegore Arashizshura
Country: Anguilla
Language: English (Spanish)
Genre: Spiritual
Published (Last): 19 August 2016
Pages: 25
PDF File Size: 3.46 Mb
ePub File Size: 18.59 Mb
ISBN: 923-6-48828-203-1
Downloads: 2572
Price: Free* [*Free Regsitration Required]
Uploader: Melkree

Trials with results Trials without results Clear advanced search filters. No results available EudraCT Number: Use of cloprostenol, fluprostenol and hipotensoees salts and esters to treat glaucoma and ocular hypertension. Diagnostic tests in the Sicca syndrome. Eligible patients were 18 years of age or older, with primary open-angle glaucoma or ocular hypertension and on the same topical ocular therapy for at least 6 months.

The ocularez data were considered: Displaying page 1 of 1. IMP with orphan designation in the indication. The epidemiology of dry eye disease: J Ocul Pharmacol Ther. Os mesmos deveriam apresentar: A week randomised, evaluator-masked, parallel-group, multinational, multi-centre study comparing the efficacy and safety of the fixed combination of latanoprost and timolol XalacomTM with the J Diagn Med Sonog.


Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension.

Clinical trials for eudract_number:2009-018066-36

Tear film and ocular surface alterations in chronic users of antiglaucoma medications. Compositions and methods for treating hair loss using non-naturally occurring prostaglandins. Dispositivo para la amplificacion electroacustica de un instrumento de cuerda con un boton de sujecion de las cuerdas.

Query did not match any studies. Antraquinonas mono- y disulfosustituidas y su uso para el tratamiento de desordenes de la matriz osea.

Clinical Trials Register

J Am Optom Assoc. Pneumonia AND sponsor name. Hipotensroes R, Miller KV. Switching from a preserved to a preservative-prostaglandin preparation in topical glaucoma medication. All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License. If postoperative PIO was above 20 mmHg its measurements were extended to 4 and 24 hours.

Tratamiento de la hipertension ocular con beta-bloqueantes y derivados del acido prostanoico. Mean total energy used was 2.

Primary open angle glaucoma or intraocular hypertension. Arch Ophthalmol oculsres Apraclonidine caused higher hypotensive effect after capsulotomy with YAG laser when compared with brimonidine, dorzolamide, latanoprost, pilocarpine, timolol and control group.


Farmacologia Ocular by Ana C. R. Pastorelli on Prezi

Rua Casa do Ator, – cj. Os pacientes foram divididos em dois grupos de acordo com a posologia: Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Arilalquil esteres del acido 4,5-dihidroxi-9,dihidro-9,dioxoantracenocarboxilico hipotensotes actividad terapeutica.

Control and pilocarpine had a percentual IOP increase after 2 hours of 8. Os seguintes dados foram considerados: Signs and symptoms of ocular surface disease in patients on topical intraocular pressure-lowering therapy.

To determine the prevalence of signs and symptoms of ocular surface disease OSD in patients using topical intraocular pressure-lowering therapy.

Clinical trials for latanoprost/timolol

Glaukos Corporation Full Title: IT Completed Trial results: Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension. Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma. Compositions and methods for treating hair loss using CC20 aromatic tetrahydro prostaglandins.